Tenghui Ma

Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial

Huabin Hu, Liang Kang, Jianwei Zhang et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 278 citations

Neoadjuvant Pd-1 Blockade, Medicine, Immunology +7

Impact of Preoperative Radiotherapy on Anastomotic Leakage and Stenosis After Rectal Cancer Resection: Post Hoc Analysis of a Randomized Controlled Trial

Qiyuan Qin, Tenghui Ma, Yanhong Deng et al. · Diseases of the Colon & Rectum · 2016 · 154 citations

Bowel Dysfunction After Low Anterior Resection With Neoadjuvant Chemoradiotherapy or Chemotherapy Alone for Rectal Cancer: A Cross-Sectional Study from China

Qiyuan Qin, Binjie Huang, Wuteng Cao et al. · Diseases of the Colon & Rectum · 2017 · 56 citations

Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with <i>RAS</i>/<i>BRAF</i> Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial

Huabin Hu, Kun Wang, Meijin Huang et al. · The Oncologist · 2020 · 46 citations · Full text

Platelet-derived growth factor C signaling is a potential therapeutic target for radiation proctopathy

Weisi Lu, Yunling Xie, Binjie Huang et al. · Science Translational Medicine · 2021 · 36 citations